Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)
China
· Delayed Price · Currency is CNY 27.87
+0.37 (1.35%)
Mar 11, 2026, 3:00 PM CST
SHA:603139 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -183.84 | -89.63 | -26.16 | -63.06 | 36.48 | 34.11 | Upgrade
|
| Depreciation & Amortization | 59.77 | 59.77 | 37.71 | 25.34 | 16.37 | 11.96 | Upgrade
|
| Other Amortization | 1.21 | 1.21 | 1.01 | 6.46 | 0.43 | 0.13 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.66 | -0.66 | -0.1 | 0.02 | - | 0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.2 | 1.2 | 16.9 | 11.53 | 0.01 | 0.1 | Upgrade
|
| Loss (Gain) From Sale of Investments | 31.15 | 31.15 | 28.74 | 54.83 | -23.44 | -4.85 | Upgrade
|
| Provision & Write-off of Bad Debts | 5.92 | 5.92 | 0.83 | 8.78 | 1.71 | 3.19 | Upgrade
|
| Other Operating Activities | 167.86 | 29.37 | 5.73 | 4.66 | 12.47 | 7.99 | Upgrade
|
| Change in Accounts Receivable | 24.45 | 24.45 | -82.39 | -26.84 | 1.25 | 33.23 | Upgrade
|
| Change in Inventory | -9.87 | -9.87 | 28.45 | -7.09 | -9.22 | -0.13 | Upgrade
|
| Change in Accounts Payable | -1.93 | -1.93 | -65.29 | 44.77 | -26.99 | 8.44 | Upgrade
|
| Change in Other Net Operating Assets | 0.26 | 0.26 | -4.82 | - | - | - | Upgrade
|
| Operating Cash Flow | 81.57 | 37.29 | -72.13 | 50.43 | 7.42 | 93.72 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 579.82% | -92.08% | -12.84% | Upgrade
|
| Capital Expenditures | -34.28 | -46.66 | -72.38 | -138.13 | -290.3 | -265.59 | Upgrade
|
| Sale of Property, Plant & Equipment | 5.6 | 6.51 | 0.32 | 0.14 | 0.08 | 0.01 | Upgrade
|
| Cash Acquisitions | -3.01 | -3.01 | 25.34 | - | -8.26 | -32.55 | Upgrade
|
| Divestitures | -3 | - | 0.98 | - | - | - | Upgrade
|
| Investment in Securities | 27.01 | 26.02 | -0.55 | 87.42 | -97.38 | 92.88 | Upgrade
|
| Other Investing Activities | 28.72 | 0.62 | 0.33 | 7.17 | 16.89 | 7.39 | Upgrade
|
| Investing Cash Flow | 21.05 | -16.52 | -45.97 | -43.4 | -378.98 | -197.86 | Upgrade
|
| Short-Term Debt Issued | - | 4.1 | 3.13 | 11.73 | 1.93 | 5.81 | Upgrade
|
| Long-Term Debt Issued | - | 340.64 | 322.65 | 231.36 | 476.9 | 58.41 | Upgrade
|
| Total Debt Issued | 281.35 | 344.74 | 325.78 | 243.1 | 478.83 | 64.22 | Upgrade
|
| Short-Term Debt Repaid | - | -8.9 | -2.05 | -0.79 | -2.77 | -7.22 | Upgrade
|
| Long-Term Debt Repaid | - | -375.61 | -235.23 | -205.62 | -65.39 | -22.38 | Upgrade
|
| Total Debt Repaid | -343.59 | -384.52 | -237.28 | -206.41 | -68.16 | -29.6 | Upgrade
|
| Net Debt Issued (Repaid) | -62.23 | -39.78 | 88.49 | 36.68 | 410.67 | 34.62 | Upgrade
|
| Common Dividends Paid | -30.09 | -28.93 | -30.73 | -32.26 | -33.38 | -9.98 | Upgrade
|
| Other Financing Activities | -19.56 | 2.71 | -3.12 | 3.17 | 1.02 | -1.31 | Upgrade
|
| Financing Cash Flow | -112.06 | -65.99 | 54.65 | 7.59 | 378.31 | 23.33 | Upgrade
|
| Net Cash Flow | -27.92 | -45.22 | -63.45 | 14.63 | 6.75 | -80.8 | Upgrade
|
| Free Cash Flow | 47.29 | -9.37 | -144.52 | -87.7 | -282.88 | -171.86 | Upgrade
|
| Free Cash Flow Margin | 9.21% | -1.67% | -21.48% | -17.84% | -63.89% | -41.51% | Upgrade
|
| Free Cash Flow Per Share | 0.48 | -0.09 | -1.44 | -0.88 | -2.87 | -1.71 | Upgrade
|
| Cash Income Tax Paid | 30.59 | 42.64 | 31.71 | -12.11 | 18.01 | 31.6 | Upgrade
|
| Levered Free Cash Flow | 112.07 | -20.57 | -123.73 | -141.29 | -237.69 | -142.09 | Upgrade
|
| Unlevered Free Cash Flow | 134.56 | 1.17 | -109.07 | -133.02 | -233.74 | -141.17 | Upgrade
|
| Change in Working Capital | -1.04 | -1.04 | -136.81 | 1.87 | -36.62 | 41.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.